Aspen Pharmacare Holdings Limited

JSE:APN Stok Raporu

Piyasa değeri: R80.0b

Aspen Pharmacare Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Aspen Pharmacare Holdings şirketinin toplam hissedar öz sermayesi ZAR84.9B ve toplam borcu ZAR35.9B olup, bu da borç-öz sermaye oranını 42.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ZAR139.2B ve ZAR54.3B dir. Aspen Pharmacare Holdings 'in FAVÖK'ü ZAR8.9B faiz karşılama oranı 7.3 dur. Şirketin ZAR12.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

42.3%

Borç/özkaynak oranı

R35.86b

Borç

Faiz karşılama oranı7.3x
NakitR12.34b
EşitlikR84.86b
Toplam yükümlülüklerR54.29b
Toplam varlıklarR139.16b

Son finansal sağlık güncellemeleri

Recent updates

Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Oct 10
Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Oct 01
Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

Sep 10
Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: APN 'nin kısa vadeli varlıkları ( ZAR44.1B ) kısa vadeli yükümlülüklerini ( ZAR24.4B ) aşıyor.

Uzun Vadeli Yükümlülükler: APN şirketinin kısa vadeli varlıkları ( ZAR44.1B ) uzun vadeli yükümlülüklerini ( ZAR29.9B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: APN 'nin net borç/öz sermaye oranı ( 27.7% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: APN 'nin borç/öz sermaye oranı son 5 yılda 88.5% seviyesinden 42.3% seviyesine düştü.

Borç Kapsamı: APN 'nin borcu işletme nakit akışı ( 17.4% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: APN 'in borcuna ilişkin faiz ödemeleri EBIT ( 7.3 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin